Aspirin Use as a Risk Factor for Marginal Ulceration in Roux-en-Y Gastric Bypass Patients: A Meta-Analysis of 24,770 Patients

Am Surg. 2023 Jun;89(6):2537-2544. doi: 10.1177/00031348221103647. Epub 2022 May 18.

Abstract

Background: Roux-en-Y gastric bypass (RYGB) is a recognized, safe bariatric procedure with minimal complications. Marginal ulceration, however, remains a challenging problem with an incidence of 8-12%. While chronic NSAID use is an established risk factor for ulcer formation, aspirin use itself as a cause for marginal ulceration is still unclear. We aim to compare the rates of marginal ulceration in RYGB with and without aspirin use.

Methods: PubMed, ScienceDirect, Cochrane, Web of Science, and Google Scholar were searched for articles between 2008 and 2021 by two independent reviewers using the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA). The risk of bias was assessed using Newcastle-Ottawa Scale. Meta-analysis was conducted using a fixed-effect model.

Results: From 5324 studies screened, we included 3 studies. Two studies had a low risk of bias, and the other one presented a high risk of bias on the Newcastle-Ottawa Scale. We included 24,770 patients, 1911 with aspirin use and 22,859 without aspirin use. After the meta-analysis, patients who used aspirin had a significantly higher marginal ulceration rate than those who did not (OR = 1.33 [95% CI 1.08 to 1.63], P < .002; I2 = 39%).

Conclusions: Aspirin use is associated with increased rates of marginal ulceration after RYGB.

Keywords: aspirin; bariatric surgery; marginal ulceration; meta-analysis; obesity.

Publication types

  • Meta-Analysis

MeSH terms

  • Aspirin / adverse effects
  • Gastric Bypass* / adverse effects
  • Gastric Bypass* / methods
  • Humans
  • Obesity, Morbid* / surgery
  • Retrospective Studies
  • Risk Factors
  • Ulcer

Substances

  • Aspirin